Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study.

Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study.

<h4>Background</h4>Parasite persistence after acute infection with Trypanosoma cruzi is an important factor in the development of Chagas disease (CD) cardiomyopathy. Few studies have investigated the clinical effectiveness of CD treatment through the evaluation of cardiological events by...

Full description

Bibliographic Details
Main Authors:	Nicolás Leonel González, Guillermo Moscatelli, Samanta Moroni, Griselda Ballering, Laura Jurado, Nicolás Falk, Andrés Bochoeyer, Alejandro Goldsman, María Grippo, Héctor Freilij, Facundo Garcia Bournissen, Eric Chatelain, Jaime Altcheh
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-12-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0010968

Similar Items

Prevention of congenital Chagas through treatment of girls and women of childbearing age
by: Guillermo Moscatelli, et al.
Published: (2015-06-01)

Longitudinal follow up of serological response in children treated for Chagas disease.
by: Guillermo Moscatelli, et al.
Published: (2019-08-01)

Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study.
by: Samanta Moroni, et al.
Published: (2016-01-01)

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina
by: Guillermo Moscatelli, et al.
Published: (2015-08-01)

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
by: Jaime Altcheh, et al.
Published: (2014-05-01)

Congenital syphilis in Argentina: Experience in a pediatric hospital.
by: Luciana Noemí Garcia, et al.
Published: (2021-01-01)

Efficacy of short-course treatment for prevention of congenital transmission of Chagas disease: A retrospective cohort study.
by: Guillermo Moscatelli, et al.
Published: (2024-01-01)

Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
by: Jean-Yves Brossas, et al.
Published: (2021-11-01)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients.
by: Tomas Duffy, et al.
Published: (2009-01-01)

Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.
by: Romina A Cutrullis, et al.
Published: (2011-01-01)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women.
by: Yves Carlier, et al.
Published: (2019-10-01)

Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review.
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2015-11-01)

The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
by: Alejandro D. Ricci, et al.
Published: (2023-04-01)

Comentarios acerca de "La enfermedad en su laberinto: avances, desafíos y paradojas de cien años del Chagas en Argentina"
by: Héctor Freilij
Published: (2012-01-01)

Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation.
by: Jaime Altcheh, et al.
Published: (2023-05-01)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2022-07-01)

Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women.
by: Yves Carlier, et al.
Published: (2011-10-01)

Chagas disease research and development: Is there light at the end of the tunnel?
by: Eric Chatelain
Published: (2017-01-01)

Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
by: Jaime Altcheh, et al.
Published: (2021-01-01)

Sex differences in patterns of referral and resource utilization in the cardiology clinic: an outpatient analysis
by: Lourdes Vicent, et al.
Published: (2023-07-01)

Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2020-10-01)

Development of vaccines for Chagas disease (CRUZIVAX): stakeholders’ preferences and potential impacts on healthcare
by: Francesco Ramponi, et al.
Published: (2023-01-01)

Women Empowerment in Cardiology
by: Sara Moscatelli, MD, et al.
Published: (2020-10-01)

Translational challenges of animal models in Chagas disease drug development: a review
by: Chatelain E, et al.
Published: (2015-08-01)

Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation.
by: Paula Sartor, et al.
Published: (2017-02-01)

Social media as an educational tool in interventional cardiology
by: Alfonso Jurado-Román
Published: (2019-05-01)

Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
by: Guadalupe Romer, et al.
Published: (2023-08-01)

Ten years follow-up of the largest oral Chagas disease outbreak: Cardiological prospective cohort study.
by: Raiza Ruiz-Guevara, et al.
Published: (2023-10-01)

Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.
by: Juan Mucci, et al.
Published: (2017-10-01)

Precision Medicine in Interventional Cardiology
by: Thijmen W Hokken, et al.
Published: (2020-04-01)

Clinical, Cardiological and Serologic Follow-Up of Chagas Disease in Children and Adolescents from the Amazon Region, Brazil: Longitudinal Study
by: Ana Yecê das Neves Pinto, et al.
Published: (2020-08-01)

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
by: Leticia L Niborski, et al.
Published: (2016-06-01)

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.
by: Analía I Porrás, et al.
Published: (2015-06-01)

Manejo conservador de la axila en cáncer de mama operable
by: Héctor D Ferreyra, et al.
Published: (2021-03-01)

ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.
by: Rocio Rivero, et al.
Published: (2023-06-01)

Derechos sexuales y la internet, antología Global Information Society Watch
by: Florencia Goldsman
Published: (2018-08-01)

Cardiology
by: Banning, A, et al.
Published: (2009)

Cardiology /
by: Lyon, Alexander R.
Published: (c201)

Cardiology /
by: Gray, Huon H
Published: (2007)